Cerevast Therapeutics Secures $1,479,154 New Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ea8aa905-bd1b-42f8-bf03-6b3652523266&Preview=1
Date
4/22/2013
Company Name
Cerevast Therapeutics
Mailing Address
12277 134th Court NE Redmond, WA 98052
Company Description
Cerevast Therapeutics, Inc. is a medical technology company with primary emphasis in the field of SonoLysis for the treatment acute ischemic stroke and other vascular disorders.
Website
http://www.cerevast.com
Transaction Type
Venture Equity
Transaction Amount
$1,479,154
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing.
M&A Terms
Venture Investor
Undisclosed